ICSE board has released the official syllabus for classes 9 to 12 to help students prepare for the board exams. Students can ...

Anthropic released a new AI model named Claude Fable 5, the first of its Mythos class on Tuesday, June 9. The newly unveiled Claude Fable 5 is a public version of Mythos, an AI model ...

This video explains how the heart, blood, and blood vessels work together to circulate oxygen, nutrients, and other vital ...

Detailed price information for Cabaletta Bio Inc (CABA-Q) from The Globe and Mail including charting and trades.

Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class therapies targeting ...

Driven by personal losses, major unmet needs and a desire to diversify from the crowded oncology market, Fosun Pharma is ...

Globally recognized Qatar Foundationresearcher Dr. Hilal A. Lashuel discusses the Parkinson s challenge facing the world, the ...

Good morning. It’s day five of the Leaving Certificate exams and Irish paper 2 is underway this morning, with Biology to follow this afternoon. After a generally well received Paper 1 yesterday, ...

Is CRVS a good stock to buy? We came across a bullish thesis on Corvus Pharmaceuticals, Inc. on Biotech Distilled’s Substack. In this article, we will summarize the bulls’ thesis on CRVS.

Company to Loan $6.5 Million Prior to Closing to Fund Order Backlog and Working Capital Needs – Combined Company to be Renamed NOMAD Power Solutions, Inc. and Trade Under a New Ticker Symbol ...

At the RP2D and maximum tolerated dose (100 µg,) cemsidomide achieved a 53% overall response rate (ORR). At the 75 µg dose level, cemsidomide achieved a 40% ORR. Across all doses evaluated, ...